Published in PLoS One on April 13, 2009
Toll-like receptor 4 in CNS pathologies. J Neurochem (2010) 1.68
Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol (2010) 1.29
Mechanisms of exercise-induced hypoalgesia. J Pain (2014) 0.86
Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study. Pain Res Treat (2013) 0.85
Regulation of spinal dynorphin 1-17 release by endogenous pituitary adenylyl cyclase-activating polypeptide in the male rat: relevance of excitation via disinhibition. J Pharmacol Exp Ther (2010) 0.82
Endogenous opioid antagonism in physiological experimental pain models: a systematic review. PLoS One (2015) 0.78
Duloxetine for the treatment of fibromyalgia. Expert Rev Clin Immunol (2010) 0.77
Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain (2016) 0.76
Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol (1988) 60.71
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
The fibromyalgia impact questionnaire: development and validation. J Rheumatol (1991) 5.94
The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol (2004) 5.20
Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse (1987) 3.54
The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol (2005) 2.98
Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol (2003) 2.56
The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol (1999) 2.44
Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain (1997) 2.34
A meta-analytic review of pain perception across the menstrual cycle. Pain (1999) 2.22
Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci (2007) 2.19
Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain (2002) 2.11
Cognitive function in fibromyalgia patients. Arthritis Rheum (2001) 2.02
Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain (2005) 2.00
Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers. Alcohol Clin Exp Res (2000) 1.62
Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man. Arch Gen Psychiatry (1973) 1.57
Epidemiology of fibromyalgia. Curr Pain Headache Rep (2003) 1.50
Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain (1996) 1.47
Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol (1992) 1.46
Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther (1996) 1.41
Sex differences in musculoskeletal pain. Clin J Pain (2001) 1.39
The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry (1993) 1.38
Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord (2004) 1.27
Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration. J Clin Psychiatry (1984) 1.18
Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics (2008) 1.14
Duration of occupancy of opiate receptors by naltrexone. J Nucl Med (1988) 1.12
Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol (2003) 1.12
Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans. Psychopharmacology (Berl) (1999) 1.10
Women's health issues with fibromyalgia syndrome. J Womens Health (Larchmt) (2006) 1.06
The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. Eur J Pain (2006) 1.05
Naltrexone biotransformation and incidence of subjective side effects: a preliminary study. Alcohol Clin Exp Res (1997) 1.04
Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability. Psychosom Med (1998) 1.03
Serum time course of naltrexone and 6 beta-naltrexol levels during long-term treatment in drug addicts. Drug Alcohol Depend (1998) 1.01
Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol (1999) 1.00
Mechanisms of induction of persistent nociception by dynorphin. J Pharmacol Exp Ther (2001) 1.00
Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry (1985) 0.94
Fibromyalgia syndrome. New associations. Am J Phys Med Rehabil (1992) 0.93
Lack of hepatotoxicity with naltrexone treatment. J Clin Pharmacol (1994) 0.92
Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers. J Pharmacol Exp Ther (1993) 0.91
Fibromyalgia: diagnosis, pathogenesis, and treatment. Curr Opin Anaesthesiol (2001) 0.87
Early life stress, negative paternal relationships, and chemical intolerance in middle-aged women: support for a neural sensitization model. J Womens Health (1998) 0.86
Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP). J Rheumatol Suppl (1989) 0.86
Naltrexone and dysphoria: a double-blind placebo controlled trial. Biol Psychiatry (1987) 0.85
No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7. Pain (1991) 0.84
Muscle pain perception and sympathetic nerve activity to exercise during opioid modulation. Am J Physiol Regul Integr Comp Physiol (2000) 0.83
The relationship between fibromyalgia and the multiple chemical sensitivity syndrome. Scand J Rheumatol (1997) 0.83
The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study. J Rheumatol Suppl (1989) 0.83
Plasma levels on nociceptin in female fibromyalgia syndrome patients. Z Rheumatol (1998) 0.82
Counter irritation test in primary fibromyalgia. Clin Rheumatol (1994) 0.82
Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheumatol (1988) 0.81
Sympathetic nervous system function in fibromyalgia. Curr Rheumatol Rep (2000) 0.81
Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain (1989) 0.80
Serum beta-endorphin in primary fibromyalgia syndrome: a controlled study. J Rheumatol (1986) 0.79
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report. Clin J Pain (2002) 0.79
Fibromyalgia: patient perspectives on symptoms, symptom management, and provider utilization. Clin Nurse Spec (2002) 0.78
Effects of naltrexone on repressive coping and disclosure of emotional material: a test of the opioid-peptide hypothesis of repression and hypertension. Psychosom Med (2006) 0.76
Pain and its modulation. Part 2. efferent mechanisms. Neurosurgery (1980) 0.76
Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav Immun (2007) 2.18
Are reports of childhood abuse related to the experience of chronic pain in adulthood? A meta-analytic review of the literature. Clin J Pain (2005) 1.53
An online mindfulness intervention targeting socioemotional regulation in fibromyalgia: results of a randomized controlled trial. Ann Behav Med (2013) 1.51
Chronic pain, stress, and the dynamics of affective differentiation. J Pers (2004) 1.29
Resilience: a new paradigm for adaptation to chronic pain. Curr Pain Headache Rep (2010) 1.18
Neighborhood contexts and the mediating role of neighborhood social cohesion on health and psychological distress among Hispanic and non-Hispanic residents. Ann Behav Med (2012) 1.16
Coping with rheumatoid arthritis pain in daily life: within-person analyses reveal hidden vulnerability for the formerly depressed. Pain (2006) 1.15
Childhood maltreatment and diurnal cortisol patterns in women with chronic pain. Psychosom Med (2010) 1.14
The effects of anxiety and depression on weekly pain in women with arthritis. Pain (2008) 1.14
Psychological resilience predicts decreases in pain catastrophizing through positive emotions. Psychol Aging (2010) 1.10
Vulnerability and resilience in women with arthritis: test of a two-factor model. J Consult Clin Psychol (2008) 1.04
Positive affect as a factor of resilience in the pain-negative affect relationship in patients with rheumatoid arthritis. J Psychosom Res (2006) 1.03
Daily affect relations in fibromyalgia patients reveal positive affective disturbance. Psychosom Med (2009) 1.02
COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain (2010) 1.02
Psychological resilience, pain catastrophizing, and positive emotions: perspectives on comprehensive modeling of individual pain adaptation. Curr Pain Headache Rep (2013) 0.99
The role of personality in exposure and reactivity to interpersonal stress in relation to arthritis disease activity and negative affect in women. Health Psychol (2002) 0.98
Affect and pain in rheumatoid arthritis: do individual differences in affective regulation and affective intensity predict emotional recovery from pain? Ann Behav Med (2005) 0.98
The role of purpose in life in recovery from knee surgery. Int J Behav Med (2004) 0.97
Older adults' recovery from surgery for osteoarthritis of the knee: psychosocial resources and constraints as predictors of outcomes. Health Psychol (2002) 0.97
Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychol (2010) 0.97
Pain acceptance moderates the relation between pain and negative affect in female osteoarthritis and fibromyalgia patients. Ann Behav Med (2007) 0.96
Adaptation to early knee osteoarthritis: the role of risk, resilience, and disease severity on pain and physical functioning. Ann Behav Med (2008) 0.96
The role of positive and negative interpersonal events on daily fatigue in women with fibromyalgia, rheumatoid arthritis, and osteoarthritis. Health Psychol (2008) 0.95
Ambulatory monitoring in the genetics of psychosomatic medicine. Psychosom Med (2012) 0.94
Socioeconomic disparities in pain: the role of economic hardship and daily financial worry. Health Psychol (2011) 0.94
The role of illness uncertainty on coping with fibromyalgia symptoms. Health Psychol (2006) 0.91
Uncertainty of illness relationships with mental health and coping processes in fibromyalgia patients. J Behav Med (2006) 0.91
Impact of two types of expectancy on recovery from total knee replacement surgery (TKR) in adults with osteoarthritis. Behav Med (2004) 0.90
Comparison of an Online Mindfulness-based Cognitive Therapy Intervention With Online Pain Management Psychoeducation: A Randomized Controlled Study. Clin J Pain (2015) 0.88
Rheumatoid arthritis patients' perceptions of mutuality in conversations with spouses/partners and their links with psychological and physical health. Arthritis Rheum (2008) 0.88
Sex differences in the relations of positive and negative daily events and fatigue in adults with rheumatoid arthritis. J Pain (2010) 0.85
State and trait pain catastrophizing and emotional health in rheumatoid arthritis. Ann Behav Med (2013) 0.85
Rethinking the fear avoidance model: toward a multidimensional framework of pain-related disability. Pain (2013) 0.84
Oscillations in daily pain prediction accuracy. Nonlinear Dynamics Psychol Life Sci (2010) 0.82
Health goal cognition and adjustment in women with fibromyalgia. J Behav Med (2005) 0.82
Attachment predicts daily catastrophizing and social coping in women with pain. Health Psychol (2011) 0.81
Relationship status and quality moderate daily pain-related changes in physical disability, affect, and cognitions in women with chronic pain. Pain (2012) 0.81
Fibromyalgia and fatigue: central processing, widespread dysfunction. PM R (2010) 0.80
The Psychosocial Context of Financial Stress: Implications for Inflammation and Psychological Health. Psychosom Med (2016) 0.80
Social resilience: the value of social fitness with an application to the military. Am Psychol (2011) 0.80
Community gardening: a parsimonious path to individual, community, and environmental resilience. Am J Community Psychol (2011) 0.79
Rheumatoid arthritis: stress affects rheumatoid arthritis, but via what mechanisms? Nat Rev Rheumatol (2013) 0.79
Individual differences in emotional processing and reactivity to pain among older women with rheumatoid arthritis. Clin J Pain (2007) 0.78
Daily interpersonal events in pain patients: applying action theory to chronic illness. J Clin Psychol (2006) 0.77
Mutuality's prospective beneficial effects on inflammation in female patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 0.76
Interpersonal workplace stressors and well-being: a multi-wave study of employees with and without arthritis. J Appl Psychol (2002) 0.75
Stress-related clinical pain and mood in women with chronic pain: moderating effects of depression and positive mood induction. Ann Behav Med (2014) 0.75
Emodiversity and Biomarkers of Inflammation. Emotion (2017) 0.75
Predictors and social consequences of daily pain expectancy among adults with chronic pain. Pain (2017) 0.75
Respiratory sinus arrhythmia: a marker of resilience to pain induction. Int J Behav Med (2014) 0.75